Goldman Sachs Lowers Price Target On Johnson & Johnson (JNJ)

Article Stock Quotes (1) Comments (0)

Earlier, Goldman Sachs lowered its price target on Neutral-rated Johnson & Johnson (NYSE: JNJ) from $74 to $72 due to increased competitive risk on core pharma franchises.

For an analyst ratings summary and ratings history on Johnson & Johnson click here. For more ratings news on Johnson & Johnson click here.

Shares of Johnson & Johnson are flat at $64.90 Monday.

---

Join StreetInsider.com FREE and get immediately alerted when news breaks on your stocks and other market items - JOIN NOW

---

*NEW - Download StreetInsider's FREE iPhone and iPad App - Click Here

---

---

You May Also Be Interested In

• Janssen Pharma (JNJ) Plans Slew of Filing, Extension Submissions by FY17
• Bulls and Bears Do Battle in Aeropostale (ARO); Turnaround Intact?
• UPDATE: A.G. Lafley Gives Procter & Gamble (PG) Investors 'New Hope', UBS Upgrades to Buy

Create E-mail Alert Related Categories

Analyst Comments

Add Your Comment

Name

Subject

Body

Share on Facebook

Verification
can't see the text?
click here to refresh the image.
what's this?